A purple and pink letter v on a white background.
April 28, 2020

5 Ways To Stay Relevant To Patients In Uncertain Times

The COVID-19 pandemic has thrown normal life out the window for the time being. Shelter-in-place orders and social distancing have put a temporary hold on many of the conveniences and activities we all probably took for granted just a few months ago.

For aestheticians and other medical clinics, waiting rooms and offices are most likely empty. When the world recovers, however, it might not be as simple as hanging the “open” sign on the door. Understandably, it may be difficult for providers to reconnect with clients and resume business as usual when the crisis finally ends.

To better ensure that your clinic doesn’t experience this problem, you need a strategy to remain relevant to patients. If you can engage with them successfully—even as your doors remain closed—you stand a much better chance of rebounding once they open.

Here are some tips to help your practice stay at the forefront of clients’ minds—even when they can’t visit your offices.

1. Take Advantage of the Time 

Just because people can’t come to your office doesn’t mean you have to twiddle your thumbs through the pandemic. This could be the golden opportunity you’ve needed to streamline and optimize your online presence.

Add content to your site that will mean something to your audience—whether it’s videos, podcasts, or blogs. Continue to use social media and maintain the dialogue you have with the public.

2. Create a Response Plan

Your patients will have questions, and it’s crucial to have answers for them. Whether they ask by calling on the phone, sending emails, or searching your website, you need to make sure they can find the information they seek.

Keep your team of representatives in the loop so they can react quickly to any inquiries. Be sure to incorporate seasonality to help content stay timely and fresh. Messaging should be honest and authentic. A canned statement won’t do much to allay concerns and could leave your audience feeling cold.

3. Reassess Your Marketing

We’re all looking for ways to feel like we did before COVID-19 struck, but that shouldn’t extend to leaving your marketing on autopilot. Take this time to re-evaluate any automated email or social media campaigns you may have established before the pandemic. The last thing you want is for patients to get a reminder about previously scheduled events or promotions that have since been scuttled.

Likewise, what was a fun and lighthearted post a few months ago might seem tone-deaf and insensitive under the current circumstances. Also, be careful to watch the volume of marketing you send. Blasting contacts with emails during a time like this can have the opposite effect from the one you want.

4. Emphasize Engagement

You want to be able to hit the ground running when the world reopens. That means having a solid core of customers and prospects who are fully engaged and ready to make an appointment as soon as they can. There are numerous creative ways to build excitement among your contact list—including hosting webinars, instituting a rewards program, and holding giveaways.

5. Be Ready to Reopen

No matter how long the COVID-19 shutdown lasts, it will end eventually. When it does, make sure you’re ready for it. Creating a marketing campaign focused on engagement is a big part of this solution, but be prepared to boost activity levels in the short term so you can build momentum.

Don’t allow operations to stagnate—incorporate as many innovations as you can right now so your value proposition is that much stronger when the lockdowns lift. Offer bundled services and rewards programs to attract clients.

Adopt telemedicine to help those who may be too nervous to venture out of the house right away. Make sure public-facing employees are ready to jump back into the swing of things and deliver exceptional service. 

Next Steps

These are difficult times for everyone, but reaching the light at the end of the tunnel may happen sooner than you think. When we do, those who are prepared will have the best chance of finding success in the post-COVID-19 world. If you are looking for support on how to reopen your clinic, contact us today by using the contact button below. We look forward to hearing from you. 

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.